Search - tctmd.com

Displaying 221 - 240 of 410

Sort: Relevancy | Date

Presentation LAA 2017

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

Presenter: M. Edip Gurol

July 21, 2017

Presentation

PFO Closure in the Gore REDUCE Clinical Trial

May 24, 2017

Presentation

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

May 24, 2017

Presentation ECHO 2017

Guidelines: Assessment of ASD and PFO and Evaluation of a Cardiac Source of Embolism

Presenter: Michael H. Picard

March 31, 2017

Presentation SIF 2017

PFO Closure for Cryptogenic Stroke Choose your Patients Well

Presenter: James A. Goldstein

March 09, 2017

Presentation TCT 2016

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Presenter: Eustaquio Maria Onorato, Richard Smalling, Robert J. Sommer

November 01, 2016

Presentation TCT 2016

The REDUCE Trial: Will It Be Positive and What Will We Learn?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John F. Rhodes

November 01, 2016

Presentation TCT 2016

What Should Be the Next Series of Clinical Trials in PFO Closure?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John D. Carroll

November 01, 2016

Presentation TCT 2016

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Presenter: Eustaquio Maria Onorato, Richard Smalling, David E. Thaler

November 01, 2016

Presentation TCT 2016

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Presenter: Eustaquio Maria Onorato, Richard Smalling

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Building a Successful PFO Closure Program

Presenter: John D. Carroll, Christian Spies

November 01, 2016

Presentation TCT 2016

Available Devices/Techniques for Closure of PFO

Presenter: John D. Carroll, Christian Spies, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

The RoPE Score: How to select pathologic PFO?

Presenter: John D. Carroll, Christian Spies, David E. Thaler

November 01, 2016

Presentation TCT 2016

What Do the Randomized Clinical Trials Tell Us and How Did the FDA Respond?

Presenter: John D. Carroll, Christian Spies

November 01, 2016

Presentation TCT 2016

Long-term Outcomes of Coarctation Stenting

Presenter: John D. Carroll, Thomas J Forbes

November 01, 2016

Presentation TCT 2016

Balloon Angioplasty Vs Bare Metal Vs Stents Covered Stents: How Do You Make the Decision?

Presenter: John D. Carroll, Thomas J Forbes, Elchanan Bruckheimer

November 01, 2016

Presentation TCT 2016

Technical Steps in Coarctation Stenting: Step-by-Step

Presenter: John D. Carroll, Thomas J Forbes, Eric Horlick

November 01, 2016

Presentation TCT 2016

Assessment of Coarctation, and Review of the Guidelines

Presenter: John D. Carroll, Thomas J Forbes, Zahid Amin

November 01, 2016

Presentation TCT 2016

New Valves for the Native RV Outflow Tract

Presenter: John P. Cheatham, Matthew J. Gillespie, Ziyad M. Hijazi

November 01, 2016

Advertisement

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

PFO Closure in the Gore REDUCE Clinical Trial

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

Guidelines: Assessment of ASD and PFO and Evaluation of a Cardiac Source of Embolism

PFO Closure for Cryptogenic Stroke Choose your Patients Well

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

The REDUCE Trial: Will It Be Positive and What Will We Learn?

What Should Be the Next Series of Clinical Trials in PFO Closure?

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Building a Successful PFO Closure Program

Available Devices/Techniques for Closure of PFO

The RoPE Score: How to select pathologic PFO?

What Do the Randomized Clinical Trials Tell Us and How Did the FDA Respond?

Long-term Outcomes of Coarctation Stenting

Balloon Angioplasty Vs Bare Metal Vs Stents Covered Stents: How Do You Make the Decision?

Technical Steps in Coarctation Stenting: Step-by-Step

Assessment of Coarctation, and Review of the Guidelines

New Valves for the Native RV Outflow Tract

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content